Click to zoom
The lung is a uniquely complex and dynamic organ, continuously interfacing with the external environment while maintaining the delicate equilibrium required for efficient gas exchange and systemic homeostasis. Its vast surface area, intricate microanatomy, and rich vascular network make it both highly specialized and inherently vulnerable to a wide spectrum of pathological insults, ranging from infectious agents and environmental toxins to immune-mediated injury and neoplastic transformation. In recent decades, rapid advances in microbiology, immunology, molecular pathology, and cancer biology have profoundly reshaped our understanding of pulmonary disease, revealing that processes once considered distinct—such as infection, chronic inflammation, tissue remodeling, and carcinogenesis—are in fact deeply interconnected and often represent sequential or overlapping stages within a unified disease continuum. It is within this evolving scientific landscape that Comprehensive Lung Disease: Infection, Pathology and Oncology has been conceived, with the aim of providing a comprehensive, cohesive, and translationally relevant framework that bridges foundational science with clinical application. This volume begins by establishing a strong grounding in the structural, physiological, and cellular architecture of the lung, including its immune defense systems and mechanisms of injury and repair, thereby equipping the reader with the essential context needed to appreciate subsequent disease processes. It then systematically explores the diverse array of respiratory pathogens—bacterial, mycobacterial, viral, fungal, parasitic, and emerging zoonotic agents—emphasizing not only their microbiological characteristics but also their complex interactions with host defense mechanisms and their role in shaping disease outcomes in an era increasingly challenged by antimicrobial resistance. Building upon this, the text delves into the pathology of lung injury, examining both acute and chronic processes such as acute respiratory distress syndrome, airway remodeling, bronchiectasis, interstitial lung diseases, occupational exposures, and vascular disorders, highlighting the structural and functional consequences of sustained inflammation and tissue damage.
A central and distinguishing feature of this book is its dedicated focus on the interplay between infection, inflammation, and carcinogenesis, where it elucidates how persistent infections and dysregulated immune responses can create a permissive microenvironment for genetic instability, epigenetic alterations, and tumor initiation, with particular attention to entities such as tuberculosis-associated malignancy, viral oncogenesis, and the emerging role of the lung microbiome. The subsequent sections provide an in-depth exploration of lung cancer biology, encompassing histological classification, molecular genetics, tumor heterogeneity, and biomarker development, reflecting the paradigm shift toward precision oncology and targeted therapeutics. Recognizing the importance of clinical applicability, the book further integrates multidisciplinary diagnostic approaches, including radiology–pathology correlation, microbiological techniques, and histopathological interpretation, supported by algorithmic frameworks and case-based discussions that mirror real-world clinical decision-making. Therapeutic strategies are addressed comprehensively, spanning antimicrobial stewardship, management of drug-resistant infections, anti-inflammatory and antifibrotic interventions, and the rapidly evolving landscape of lung cancer treatment, including targeted therapy and immunotherapy, alongside supportive and critical care considerations.
Finally, the text extends its scope to encompass special populations and future directions, addressing lung disease in immunocompromised hosts, regional and occupational health challenges, and transformative innovations such as artificial intelligence and precision medicine that are poised to redefine pulmonary diagnostics and therapeutics. Intended for clinicians, pathologists, microbiologists, researchers, and advanced trainees, this book aspires not only to consolidate current knowledge but also to foster an integrated perspective that reflects the true complexity of lung disease, encouraging a shift away from fragmented understanding toward a more holistic and interconnected approach that will ultimately enhance research, diagnosis, and patient care in the years to come.